Camidanlumab Tesirine
ADC Therapeutics,genmab
['hodgkin', 'pivotal', 'lymphoma', '$gmab']
adc therapeutics announces results from pivotal phase 2 clinical trial of #camidanlumab tesirine (cami) in relapsed or refractory #hodgkin lymphoma $adct $gmab #genmab #royalties #eha2022 
Former Derivatives Sales & Structuring turned Trader.                   
Recipe for disaster...?                                
Mainly DAX & S&P, some biotech